# Eli Lilly Employer Connect

**Type:** Direct-to-employer distribution channel
**Parent:** Eli Lilly
**Domain:** GLP-1 access infrastructure
**Status:** Active
**Launch:** March 5, 2026

## Overview

Eli Lilly Employer Connect is a direct-to-employer channel offering Zepbound at $449/dose (55-60% below retail pricing of $1,000+), bypassing traditional PBM intermediation.

## Program Structure

**Pricing:**
- $449/dose Zepbound
- 55-60% discount versus retail ($1,000+)

**Distribution partners (15+):**
- GoodRx
- Teladoc
- Calibrate
- Form Health
- Waltz
- [Additional partners not specified in source]

**Strategic positioning:**
- Bypasses PBM formulary control
- Provides behavioral support infrastructure through program administrator partnerships
- Establishes direct manufacturer-employer relationship

## Market Context

Launched in parallel with Novo Nordisk direct-to-employer channels (January 1, 2026 via Waltz Health and 9amHealth), representing manufacturer response to PBM-controlled managed-access infrastructure.

Competes with:
- Evernorth EncircleRx
- Optum Rx Weight Engage
- UHC Total Weight Support

## Timeline

- **March 5, 2026** — Employer Connect launched with $449/dose pricing and 15+ program administrator partnerships